Regimen-related toxicity busulfan-cyclophosphamide conditioning regimen patients undergoing allogeneic bone marrow transplantation regimen-related toxicity RRT busulfan mg/kg cyclophosphamide mg/kg regimen BuCy consecutive patients allogeneic bone marrow transplantation hematologic malignancies Patients toxicity gradings organ systems cardiac bladder renal pulmonary hepatic CNS stomatic gastrointestinal RRT scale set patient disease treatment parameters age sex diagnosis Eastern Cooperative Oncology Group ECOG score liver function tests LFT chemotherapy exposure disease status graft-versus-host disease GVHD prophylaxis antimicrobial agent use hematologic recovery severity acute GVHD significant predictors RRT common significant organ toxicities stomatic patients grades II IV hepatic patients grades II IV Renal gastrointestinal toxicities uncommon serious grades II IV patients grade III toxicities following systems hepatic pulmonary CNS Females frequent stomatitis hepatic RRT Patients methotrexate GVHD prophylactic regimen grade II IV stomatitis hepatic RRT use amphotericin antibiotic courses grades II IV hepatic RRT multivariate analysis administration grades II IV hepatic RRT incidence acute GVHD grades II IV GVHD estimated event-free survival EFS entire study group estimated EFS standard-risk patients acute leukemia first remission chronic myelogenous leukemia CML first stable phase others high-risk patients High-risk patients risk disease recurrence RRT BuCy efficacious bone marrow transplant regimen standard-risk patients leukemia significant hepatic RRT 